Iterum Therapeutics plc (ITRM)
NASDAQ: ITRM · Real-Time Price · USD
0.166
+0.001 (0.30%)
Mar 9, 2026, 2:50 PM EDT - Market open
Iterum Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 9 | 49 | 26 | 10 | 72 | 49 | |
| Market Cap Growth | -82.98% | 84.01% | 157.57% | -85.65% | 47.53% | -27.45% | |
| Enterprise Value | 31 | 57 | 11 | -22 | 16 | 86 | |
| Last Close Price | 0.17 | 1.77 | 1.97 | 0.84 | 5.88 | 14.83 | |
| PS Ratio | 22.42 | - | - | - | - | - | |
| PB Ratio | - | -11.93 | -4.13 | 0.37 | 1.43 | -0.96 | |
| P/TBV Ratio | - | - | - | 0.39 | 1.53 | - | |
| EV/Sales Ratio | 80.71 | - | - | - | - | - | |
| Debt / Equity Ratio | -4.57 | -11.17 | -3.05 | 1.08 | 0.61 | -0.95 | |
| Net Debt / Equity Ratio | -3.08 | -5.26 | 0.69 | -1.10 | -1.01 | -0.62 | |
| Net Debt / EBITDA Ratio | -1.18 | -1.17 | 0.10 | 1.07 | 2.27 | -0.98 | |
| Net Debt / FCF Ratio | -1.16 | -0.80 | 0.11 | 1.66 | 3.20 | -0.57 | |
| Asset Turnover | 0.02 | - | - | - | - | - | |
| Quick Ratio | 1.80 | 1.37 | 1.79 | 6.76 | 6.38 | 0.49 | |
| Current Ratio | 2.13 | 1.41 | 1.89 | 6.89 | 6.43 | 0.52 | |
| Return on Equity (ROE) | - | - | -355.35% | -113.59% | - | - | |
| Return on Assets (ROA) | -53.28% | -32.98% | -63.74% | -23.98% | -24.68% | -68.59% | |
| Return on Capital Employed (ROCE) | -79.20% | -69.30% | -372.60% | -52.60% | -31.20% | 360.70% | |
| Earnings Yield | -308.33% | -50.87% | -144.97% | -432.40% | -127.86% | -107.14% | |
| FCF Yield | -223.32% | -54.97% | -148.65% | -180.37% | -22.21% | -112.36% | |
| Buyback Yield / Dilution | -124.80% | -51.97% | -5.93% | -12.35% | -580.42% | -65.38% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.